The next industrial revolution will be biological. By turning cells into factories, synthetic biology changes how we make everything from plastic, to food, to medicine. The industry is already tackling more effective cancer treatments, growing more sustainable food, and turning waste into products.
However, a significant challenge prevents the field's growth – DNA design. DNA design is a complex, time-intensive task still reliant on trial and error. Without effective design tools, the cost of going from an idea to a testable prototype is preventing exploration in the field.
In this webinar, Davide De Lucrezia of Doulix will present a case study for the rapid design and manufacturing of complex metabolic pathways using AI-powered, computer-aided design software. The software platform allows researchers to automatically design and optimize error-free DNA fragments, making for a simpler design, swapping trial and error for predictability, and radically reducing time to prototype.